Why is Senores Pharma. falling/rising?

As of 04-Jul, Senores Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 567.10, reflecting a decrease of 3.4 points or 0.6%. The stock has underperformed its sector by 1.11% today and has been on a consecutive decline for the last four days, resulting in a total drop of 2.89% during this period. Despite showing a positive performance over the past month with a return of 10.44%, the stock has underperformed year-to-date with a slight decline of 0.32%. Additionally, the stock's delivery volume has decreased by 11.22% compared to the five-day average, indicating falling investor participation. While the company boasts a healthy growth rate in net sales and operating profit, it faces challenges such as a flat result in December 2024 and an expensive valuation reflected by a Price to Book Value of 3.3. Furthermore, institutional investors have reduced their stake by 10.3%, which may negatively impact market sentiment.
In the broader market context, the stock's short-term performance has been relatively better than the benchmark Sensex, which has declined by 0.74% over the past week. However, the year-to-date performance of Senores Pharmaceuticals is lagging behind the Sensex, which has gained 6.77%. This contrast suggests that while the stock had a strong month, its recent struggles and declining investor interest may be overshadowing its longer-term growth potential. The overall market conditions, combined with the company's recent performance and investor sentiment, contribute to the current downward trend in the stock price.